肿瘤消融的全球负担：流行病学和统计
**免责声明：**本文仅供参考，并不构成医疗建议。如有任何健康问题或在做出与您的健康或治疗相关的任何决定之前，请务必咨询合格的医疗保健专业人员。
我。简介
癌症仍然是一个严峻的全球健康挑战，其特点是全球发病率高、死亡率高。作为主要死亡原因，癌症给全球医疗保健系统、经济和个人带来了巨大负担。面对这种普遍存在的疾病，医学科学不断寻求创新和有效的治疗方式，以改善患者的治疗结果和生活质量。在这些进步中，肿瘤消融疗法已成为各种实体器官肿瘤综合管理的重要组成部分。这些微创技术可以有针对性地破坏癌组织，通常为传统手术干预提供可行的替代方案或辅助手段。
本文旨在全面概述肿瘤消融的全球负担，深入研究其流行病学和相关统计数据。我们将探讨当前癌症发病率和死亡率的现状、消融疗法的原理和类型及其在精准肿瘤学中不断发展的作用。通过综合最近的研究和临床数据，本次讨论旨在让患者和医疗保健专业人员了解这些先进治疗方案在更广泛的全球癌症护理背景下的重要性和潜力。
二。全球癌症格局
癌症对全球的影响是惊人的，每年报告的新病例和死亡数以百万计。根据 GLOBOCAN 2022 估计，2022 年全球将新增近 2000 万癌症病例和 970 万癌症死亡病例，其中包括非黑色素瘤皮肤癌 [1]。这些数字强调了有效预防、早期发现和治疗策略的迫切需要。癌症负担在全球范围内的分布并不均匀，发病率和死亡率存在显着的地区差异。例如，预计 2022 年几乎一半的新癌症病例 (49.2%) 和大部分癌症死亡病例 (56.1%) 发生在亚洲 [1]。相比之下，澳大利亚/新西兰等地区报告的发病率超过每 10 万人中 500 例，而西非的男性发病率低于每 10 万人中 100 例[1]。
肺癌仍然是全球最常诊断的癌症，也是癌症相关死亡的主要原因，到 2022 年，肺癌将导致约 250 万新发病例（占所有癌症的 12.4%）和 180 万例死亡（18.7%）[1]。其他常见的癌症类型包括女性乳腺癌（11.6%）、结直肠癌（9.6%）、前列腺癌（7.3%）和胃癌（4.9%）[1]。这些癌症的高患病率，加上其治疗相关的挑战，凸显了对多样化治疗方法的迫切需求。
A significant challenge in cancer management is the ineligibility of many patients for surgical resection, often considered the gold standard for early-stage solid tumors. For example, more than 60-80% of patients with lung cancer are deemed ineligible for surgical intervention at the time of diagnosis due to locally advanced disease or distant metastases [2]. Furthermore, factors such as advanced age, significant comorbidities, poor cardiopulmonary function, or patient refusal can preclude individuals from undergoing surgery [2]. In such scenarios, minimally invasive and non-surgical treatments, including various forms of local ablation therapy, have emerged as vital alternatives, offering hope and improved outcomes for a substantial patient population.
三。了解肿瘤消融
Local ablation therapy (LAT) encompasses a range of minimally invasive techniques designed to destroy cancerous tissue *in situ* while preserving surrounding healthy structures.这些疗法对于不适合手术的患者或适合局部治疗的肿瘤特别有价值。 The fundamental principle behind LAT involves delivering energy or chemical agents directly to the tumor, inducing cellular necrosis and subsequent tumor regression.
消融技术可大致分为化学消融和能量消融。化学消融涉及将乙醇等物质直接注射到肿瘤中以导致细胞死亡。 Energy-based ablation, which is more commonly employed, utilizes various forms of energy to generate extreme temperatures (thermal ablation) or mechanical disruption (non-thermal ablation) within the tumor. Thermal ablation techniques include radiofrequency ablation (RFA), microwave ablation (MWA), and cryoablation (CA), while non-thermal methods include high-intensity focused ultrasound (HIFU) and histotripsy.
微创消融的优点很多，并有助于其在肿瘤学中越来越多的采用。 These benefits include reduced invasiveness compared to traditional surgery, shorter hospital stays, decreased recovery times, and often, a lower risk of complications. Furthermore, LAT can be highly effective in achieving local tumor control, particularly for smaller lesions, and can be performed repeatedly if new lesions emerge or initial treatment is incomplete. The ability to precisely target and destroy tumors while protecting adjacent vital tissues makes ablation a powerful tool in the evolving landscape of cancer care [2].
四。消融治疗的流行病学和统计
The field of oncology ablation has witnessed significant growth and evolution over the past few decades, driven by technological advancements and a growing body of clinical evidence supporting its efficacy and safety. Research in this area has expanded considerably, with a steady increase in the number of publications on local ablation therapy for various malignancies, particularly between 2008 and 2023 [2]. This surge in research activity reflects the increasing recognition of ablation as a valuable treatment modality in the oncologist's armamentarium.
Geographically, research and application of ablation therapies are most prominent in countries with advanced healthcare systems and high cancer prevalence.中国、美国和日本已成为该领域的领导者，贡献了大部分出版物和临床试验[2]。 This global interest has fostered the development of various ablation technologies, each with its unique mechanisms, applications, and statistical outcomes.
射频消融 (RFA)
RFA 是最成熟和最广泛使用的热消融技术之一。它利用高频电流产生热量并诱导肿瘤内凝固性坏死。 RFA has demonstrated impressive efficacy in treating small to medium-sized tumors, with local control rates of 70-90% and 5-year survival rates of 30-50% for tumors between 1-3 cm in size [2]. However, its effectiveness can be limited by the "heat sink effect," where blood flow in adjacent vessels dissipates heat and reduces the ablative temperature, potentially leading to incomplete tumor destruction.
微波消融 (MWA)
MWA 作为一种热消融技术因其相对 RFA 的优势而受到欢迎。它利用电磁微波在更大的区域内更快地产生热量，从而不易受到散热器效应的影响。 MWA 对多种实体瘤有效，包括肝、肺、肾、前列腺和骨中的实体瘤。最近的创新，例如定向 MWA 和新颖的天线设计，进一步提高了其精度和有效性 [2]。
冷冻消融（CA）
冷冻消融通过利用极冷来冷冻和破坏癌细胞，提供了一种独特的肿瘤破坏方法。 This technique involves circulating cryogenic gases through probes inserted into the tumor, creating an ice ball that engulfs and destroys the targeted tissue. CA provides several advantages, including better preservation of surrounding tissues, reduced pain, and real-time visualization of the ablation zone. It has shown promising results in treating tumors in the kidney, liver, lung, breast, prostate, skin, and bone, with a 5-year overall survival rate of 67.8% reported for early-stage non-small cell lung cancer (NSCLC) [2].
高强度聚焦超声 (HIFU)
HIFU is a non-invasive ablation technique that uses focused ultrasound waves to generate localized heat and destroy tumor tissue without the need for incisions. Its high precision and non-invasive nature make it an attractive option for treating a variety of solid tumors, including those in the liver, prostate, pancreas, breast, and bone. HIFU can also be used for sonoporation, a technique that uses ultrasound to temporarily increase the permeability of cell membranes, enhancing the delivery of chemotherapy drugs to the tumor [3].
组织解剖学
Histotripsy is a novel, non-thermal, and non-invasive ablation technique that uses focused ultrasound pulses to create a cloud of microbubbles that mechanically disintegrate tumor tissue. This purely mechanical destruction process avoids the thermal damage associated with other ablation methods, offering a high degree of precision and safety. Histotripsy has also been shown to induce an immune response against the tumor, potentially leading to the destruction of untreated tumors through the abscopal effect [3].
V。肿瘤消融的未来趋势和挑战
肿瘤消融的前景在不断发展，正在进行的研究重点是增强其疗效、扩大其应用以及将其与其他癌症治疗相结合。最有前途的发展领域之一是探索**联合疗法**，其中消融与免疫疗法、化疗和靶向治疗等全身治疗结合使用。研究表明，热消融与免疫检查点抑制剂（ICIs）相结合可以产生协同效应，改善抗肿瘤反应并降低复发和转移的风险[2]。这种方法利用消融的能力来诱导免疫原性细胞死亡，释放肿瘤抗原，从而启动免疫系统攻击残留或远处的癌细胞。
**技术进步**也正在推动肿瘤消融的未来。机器人支气管镜等创新正在提高肺部恶性肿瘤消融手术的精度和可及性。用于药物输送系统的纳米颗粒的开发正在彻底改变治疗药物向癌性病变输送的方式，确保更有针对性和更有效的治疗，同时降低全身毒性[2]。高频 MWA 和先进的冷冻消融技术不断完善，以创建更大、更精确的消融区域，最大限度地减少对健康组织的损害。
尽管取得了这些进步，但仍然存在一些**挑战**。迫切需要**标准化方案**和指南来在不同癌症类型和阶段应用各种消融技术。国际合作和协作努力对于共享知识、标准化程序和加快研究步伐至关重要[2]。此外，高度重视**质量研究**，特别是多中心随机对照试验，对于产生高水平证据至关重要，这些证据可以进一步将消融疗法确立为护理标准选择并指导临床决策。我们的目标是超越简单地增加出版物数量，转而专注于显着改善患者治疗结果和生活质量的研究 [2]。
六。结论
肿瘤消融疗法是全球抗癌斗争中一个充满活力且日益重要的组成部分。随着全球癌症发病率和负担持续上升，这些微创技术为越来越多的患者，特别是那些不适合接受传统手术的患者提供了有效的、有针对性的解决方案。从 RFA 和 MWA 等成熟方法到 HIFU 和组织解剖学等新兴技术，各种各样的消融方法为临床医生提供了强大的工具来实现局部肿瘤控制、改善患者的生活质量和延长生存期。
消融技术的不断发展，加上它们与多模式治疗策略的整合，凸显了癌症治疗的光明前景。尽管与标准化相关的挑战以及对更强有力的临床证据的需求仍然存在，但正在进行的研究和国际合作正在为更精确、个性化和有效的癌症治疗铺平道路。展望未来，肿瘤消融的作用将进一步扩大，为患者和医疗保健提供者在与这种复杂疾病的持续斗争中带来新的希望。
**免责声明：**本文仅供参考，并不构成医疗建议。如有任何健康问题或在做出与您的健康或治疗相关的任何决定之前，请务必咨询合格的医疗保健专业人员。
参考文献
1. Bray F、Laversanne M、Sung H 等人。 2022 年全球癌症统计数据：GLOBOCAN 对全球 185 个国家 36 种癌症的发病率和死亡率的估计。加州癌症临床杂志 2024 年；74:229-63。 [https://acsjournals.onlinelibrary.wiley.com/doi/full/10.3322/caac.21834] 2. 魏燕宁，殷燕生，宁华富，王新征，邵文文，董鹏，袁凯东，王光泽。肺部恶性肿瘤局部消融的全球现状和趋势：文献计量和可视化分析。胸科杂志 2025；17(8):5417-5428。 [https://jtd.amegroups.org/article/view/103994/html] 3. Fazlollahi F，Makary MS。精准肿瘤学：微创消融治疗在实体器官肿瘤治疗中的作用。世界放射学杂志 2025 年 1 月 28 日；17(1):98618。 [https://pmc.ncbi.nlm.nih.gov/articles/PMC11755905/]